Endospan hits enrolment milestone in aortic arch stent trial

Endospan has completed enrollment in a clinical trial for its NEXUS stent graft treating aortic arch disease. The trial aims to support FDA approval and enhance patient outcomes. The company raised $25m for this endeavor, targeting a growing global market for aortic stent grafts.